SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anthem, Inc. – ‘10-Q’ for 6/30/18 – ‘EX-10.2(H)’

On:  Wednesday, 7/25/18, at 12:22pm ET   ·   For:  6/30/18   ·   Accession #:  1156039-18-10   ·   File #:  1-16751

Previous ‘10-Q’:  ‘10-Q’ on 4/25/18 for 3/31/18   ·   Next:  ‘10-Q’ on 10/31/18 for 9/30/18   ·   Latest:  ‘10-Q’ on 4/18/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 7/25/18  Anthem, Inc.                      10-Q        6/30/18   98:14M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    952K 
 2: EX-10.2(H)  Material Contract                                   HTML     89K 
 3: EX-10.2(I)  Material Contract                                   HTML     91K 
 4: EX-10.2(J)  Material Contract                                   HTML    100K 
 5: EX-10.9(D)  Material Contract                                   HTML     89K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
16: R1          Document And Entity Information                     HTML     50K 
17: R2          Consolidated Balance Sheets                         HTML    157K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     52K 
19: R4          Consolidated Statements Of Income                   HTML    101K 
20: R5          Consolidated Statements of Comprehensive Income     HTML     55K 
21: R6          Consolidated Statements Of Cash Flows               HTML    160K 
22: R7          Consolidated Statements Of Shareholders' Equity     HTML     82K 
23: R8          Organization                                        HTML     36K 
24: R9          Basis Of Presentation and Significant Accounting    HTML     59K 
                Policies                                                         
25: R10         Business Acquisitions                               HTML     40K 
26: R11         Investments                                         HTML    256K 
27: R12         Derivative Financial Instruments Derivative         HTML    257K 
                Financial Instruments                                            
28: R13         Fair Value                                          HTML    418K 
29: R14         Income Taxes                                        HTML     36K 
30: R15         Retirement Benefits                                 HTML     83K 
31: R16         Medical Claims Payable                              HTML    121K 
32: R17         Debt                                                HTML     52K 
33: R18         Commitments And Contingencies                       HTML     61K 
34: R19         Capital Stock                                       HTML    114K 
35: R20         Accumulated Other Comprehensive Income              HTML    109K 
36: R21         Earnings Per Share                                  HTML     48K 
37: R22         Segment Information                                 HTML    151K 
38: R23         Basis of Presentation and Significant Accounting    HTML     68K 
                Policies (Policies)                                              
39: R24         Investments (Tables)                                HTML    260K 
40: R25         Derivative Financial Instruments (Tables)           HTML    267K 
41: R26         Fair Value (Tables)                                 HTML    403K 
42: R27         Retirement Benefits (Tables)                        HTML     82K 
43: R28         Medical Claims Payable (Tables)                     HTML    123K 
44: R29         Debt (Tables)                                       HTML     36K 
45: R30         Capital Stock (Tables)                              HTML    118K 
46: R31         Accumulated Other Comprehensive Income (Tables)     HTML    111K 
47: R32         Earnings Per Share (Tables)                         HTML     44K 
48: R33         Segment Information (Tables)                        HTML    159K 
49: R34         Organization (Details)                              HTML     36K 
50: R35         Basis of Presentation and Signficant Accounting     HTML     43K 
                Policies Basis of Presentation and Significant                   
                Acconting Policies (Details)                                     
51: R36         Business Acquisitions Business Acquisition (Assets  HTML     67K 
                Liabilities Acquired) (Details)                                  
52: R37         Investments (Current And Long-Term Fixed Maturity   HTML     82K 
                Securities, Available-For-Sale) (Details)                        
53: R38         Investments (Aggregate Fair Value And Gross         HTML     77K 
                Unrealized Loss Of Fixed Maturity Securities In An               
                Unrealized Loss Position) (Details)                              
54: R39         Investments (Amortized Cost And Fair Value Of       HTML     67K 
                Fixed Maturity Securities, By Contractual                        
                Maturity) (Details)                                              
55: R40         Investments (Proceeds and Realized Gains Losses     HTML     37K 
                From Fixed Maturity Securities) (Details)                        
56: R41         Investments (Current and Long-term Equity           HTML     46K 
                Securities) (Details)                                            
57: R42         Investments (Gains and Losses Recognized on Equity  HTML     38K 
                Securities) (Details)                                            
58: R43         Investments (Securities Lending Programs)           HTML     45K 
                (Details)                                                        
59: R44         Investments (Narrative) (Details)                   HTML     47K 
60: R45         Derivative Financial Instruments (Notional          HTML     76K 
                Amounts, Balance Sheet Location And Estimated Fair               
                Values Of Derivative Financial Instruments)                      
                (Details)                                                        
61: R46         Derivative Financial Instruments (Summary Of        HTML     64K 
                Outstanding Fair Value Hedges) (Details)                         
62: R47         Derivative Financial Instruments Derivative         HTML     37K 
                Financial Instruments (Fair Value Hedges,                        
                Financial Position) (Details)                                    
63: R48         Derivative Financial Instruments (Effect Of Cash    HTML     41K 
                Flow Hedges On Financial Statements) (Details)                   
64: R49         Derivative Financial Instruments (Income Statement  HTML     55K 
                Relationship of Fair Value and Cash Flow Hedging)                
                (Details)                                                        
65: R50         Derivative Financial Instruments (Effect Of         HTML     41K 
                Non-Hedging Derivatives On Income Statement And                  
                Included In Net Realized Gains (Losses) On                       
                Financial Instruments) (Details)                                 
66: R51         Derivative Financial Instruments (Financial         HTML     52K 
                Statement Narrative) (Details)                                   
67: R52         Fair Value (Fair Value Measurements By Level For    HTML    155K 
                Assets Measured At Fair Value On A Recurring                     
                Basis) (Details)                                                 
68: R53         Fair Value (Reconciliation Of The Beginning And     HTML     81K 
                Ending Balances Of Assets Measured At Fair Value                 
                On A Recurring Basis Using Level III Inputs)                     
                (Details)                                                        
69: R54         Fair Value (Carrying And Estimated Fair Values by   HTML     61K 
                Level Of Financial Instruments Not Recorded At                   
                Fair Value On Consolidated Balance Sheet)                        
                (Details)                                                        
70: R55         Income Taxes (Narrative) (Details)                  HTML     38K 
71: R56         Retirement Benefits (Components Of Net Periodic     HTML     53K 
                (Benefit Credit) Benefit Cost) (Details)                         
72: R57         Medical Claims Payable (Reconciliation Of The       HTML     74K 
                Beginning And Ending Balances For Medical Claims                 
                Payable By Segment) (Details)                                    
73: R58         Medical Claims Payable (Reconciliation Of Net       HTML     42K 
                Incurred Medical Claims To Benefit Expense)                      
                (Details)                                                        
74: R59         Medical Claims Payable (Narrative) (Details)        HTML     44K 
75: R60         Debt (Carrying Value Of Long-term Debt) (Details)   HTML     38K 
76: R61         Debt (Convertible Debenture Details) (Details)      HTML     45K 
77: R62         Debt (Narrative) (Details)                          HTML    123K 
78: R63         Commitments And Contingencies (Details)             HTML     51K 
79: R64         Capital Stock (Summary of Cash Dividend Activity)   HTML     42K 
                (Details)                                                        
80: R65         Capital Stock (Summary of Share Repurchases)        HTML     44K 
                (Details)                                                        
81: R66         Capital Stock (Summary of Stock Option Activity)    HTML     68K 
                (Details)                                                        
82: R67         Capital Stock (Nonvested Restricted Stock Activity  HTML     55K 
                Including Restricted Stock Units) (Details)                      
83: R68         Capital Stock (Fair Values of Options Granted       HTML     39K 
                During The Period Estimated Using Weighted-Average               
                Assumptions) (Details)                                           
84: R69         Capital Stock (Schedule Of Weighted-Average Fair    HTML     34K 
                Values Determined For The Periods) (Details)                     
85: R70         Capital Stock (Narrative) (Details)                 HTML     89K 
86: R71         Accumulated Other Comprehensive Loss                HTML     90K 
                (Reconciliation Of The Components Of Accumulated                 
                Other Comprehensive Income) (Details)                            
87: R72         Accumulated Other Comprehensive Income (Other       HTML     54K 
                Comprehensive Income (Loss) Reclassification                     
                Adjustments) (Details)                                           
88: R73         Accumulated Other Comprehensive Income (Loss)       HTML     50K 
                Accumulated Other Comprehensive Income                           
                Reclassification Adjustments (Details)                           
89: R74         Earnings Per Share (Denominator For Basic And       HTML     37K 
                Diluted Earnings Per Share) (Details)                            
90: R75         Earnings Per Share (Narrative) (Details)            HTML     40K 
91: R76         Segment Information (Financial Data By Reportable   HTML     42K 
                Segment) (Details)                                               
92: R77         Segment Information Segment Information (Major      HTML     52K 
                Product Revenues for Each Reportable Segment)                    
                (Details)                                                        
93: R78         Segment Information (Reconciliation Of Reportable   HTML     42K 
                Segments Operating Revenues To Total Revenues                    
                Reported In The Consolidated Statements Of Income)               
                (Details)                                                        
94: R79         Segment Information (Reconciliation Of Reportable   HTML     51K 
                Segments Operating Gain To Income Before Income                  
                Tax Expense Included In The Consolidated                         
                Statements Of Income) (Details)                                  
95: R80         Segment Information Segment Information             HTML     31K 
                (Narrative) (Details)                                            
97: XML         IDEA XML File -- Filing Summary                      XML    185K 
96: EXCEL       IDEA Workbook of Financial Reports                  XLSX    125K 
10: EX-101.INS  XBRL Instance -- antm-20180630                       XML   5.19M 
12: EX-101.CAL  XBRL Calculations -- antm-20180630_cal               XML    307K 
13: EX-101.DEF  XBRL Definitions -- antm-20180630_def                XML   1.04M 
14: EX-101.LAB  XBRL Labels -- antm-20180630_lab                     XML   2.39M 
15: EX-101.PRE  XBRL Presentations -- antm-20180630_pre              XML   1.49M 
11: EX-101.SCH  XBRL Schema -- antm-20180630                         XSD    236K 
98: ZIP         XBRL Zipped Folder -- 0001156039-18-000010-xbrl      Zip    390K 


‘EX-10.2(H)’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 10.2(h)

Schedule A
Notice of Option Grant
Participant:        [●]
Company:        Anthem, Inc.
Notice:
You have been granted the following nonqualified stock option to purchase shares of common stock of the Company in accordance with the terms of the Plan and the attached Nonqualified Stock Option Award Agreement.
Plan:    2017 Anthem Incentive Compensation Plan
Grant:            Grant Date:  [●]
            Option Price per Share: $[●]
            Number of Shares under Option:  [●]

Exercisability:
Subject to the terms of the Plan and this Agreement, your Option will become exercisable on and after the dates indicated below as to the number of Shares set forth below opposite each such date, plus any Shares as to which your Option could have been exercised previously but was not so exercised.

Shares
Date
 
 
 
 
 
 
 
 
 
 
 
 

In the event that a Change of Control (as defined in the Plan) occurs before your Termination, your Option will remain subject to the terms of this Agreement, unless the successor company does not assume your Option. If a successor company does not assume your Option, then your Option shall become fully exercisable immediately prior to the Change of Control.
Expiration Date:
Your Option will expire ten years from the Grant Date, subject to earlier termination as set forth in the Plan and this Agreement.
Acceptance:
In order to accept your Options, you must electronically accept this Agreement through the Company’s broker at any time within ninety (90) days after the Grant Date. To effect your acceptance, please follow the instructions included with your grant materials. Acceptance of the Agreement includes acceptance of the terms and conditions of the Plan. If you do not timely and electronically accept this Agreement, this Agreement will be null and void as of the 90th day after the Grant Date and you will have no right or claim to the Options described above.






2018 Stock Option Agreement

Exhibit 10.2(h)

Nonqualified Stock Option Award Agreement

This Nonqualified Stock Option Award Agreement (this “Agreement”) dated as of the Grant Date (the “Grant Date”) set forth in the Notice of Option Grant attached as Schedule A hereto (the “Grant Notice”) is made between Anthem, Inc. (the “Company”) and the Participant set forth in the Grant Notice. The Grant Notice is included in and made part of this Agreement.

1.    Grant of the Option. Subject to the provisions of this Agreement and the provisions of the Plan, the Company hereby grants to the Participant, pursuant to the Plan, the right and option (the “Option”) to purchase all or any part of the number of shares of common stock of the Company (“Shares”) as set forth in the Grant Notice at an Option Price (“Option Price”) per share and on the other terms as set forth in the Grant Notice. This Option is intended to be a nonqualified stock option for federal income tax purposes.

2.
Method of Exercise of the Option.

(a)The Participant may exercise the Option, to the extent then exercisable, by delivering a notice to the Company’s captive broker in a form specified or accepted by the captive broker, specifying the number of Shares with respect to which the Option is being exercised.

(b)At the time the Participant exercises the Option, the Participant shall pay the Option Price of the Shares as to which the Option is being exercised and applicable taxes (i) in United States dollars by personal check, bank draft or money order; (ii) subject to such terms, conditions and limitations as the Compensation Committee of the Board of Directors of the Company (“Committee”) may prescribe, by tendering (either by actual delivery or attestation) unencumbered Shares previously acquired by the Participant having an aggregate Fair Market Value at the time of exercise equal to the total Option Price of the Shares for which the Option is so exercised; (iii) subject to such terms, conditions and limitations as the Committee may prescribe, a cashless (broker-assisted) exercise that complies with all applicable laws; or (iv) by a combination of the consideration provided for in the foregoing clauses (i), (ii) and (iii).
3.Termination. The Option shall terminate upon the Participant’s Termination for any reason and no Shares may thereafter be purchased under the Option except as provided below. Notwithstanding anything contained in this Agreement, (i) a Participant who is in a position of Vice President or above must give at least 30 days advance written notice of his Termination due to resignation (including Retirement) in order for the Participant to exercise the Option for any period that may apply below and (ii) in no event shall the Option be exercisable after the Expiration Date. If less than 30 days advance written notice is given, the Option shall be immediately canceled, including the portion of the Option that is otherwise exercisable.

(a)Retirement. If the Participant’s Termination is due to Retirement (for purposes of this Agreement, defined as the Participant’s Termination after attaining age fifty-five (55) with at least ten (10) completed years of service or after attaining age sixty-five (65)), the Option shall continue to become exercisable according to the schedule set forth in the Grant Notice; provided that the Option shall terminate on the five-year anniversary of the date of the Participant’s Retirement but not later than the Expiration Date noted on the attached Schedule A; provided, further, that if the Participant’s Termination is due to Retirement during the calendar year of the Grant Date, the Option shall be immediately terminated on a pro-rata basis, measured by the number of completed full months in that calendar year during which the Participant was employed by the Company or an Affiliate (e.g., if the Participant’s Retirement occurs in September, 33.3% (or 4/12) of the Option shall be immediately terminated), and the non-terminated portion of the Option shall continue to become exercisable according to the schedule set forth in the Grant Notice. This retirement provision is deleted in non-annual retention grants.1 


___________________________________________________
1 This retirement provision is deleted in non-annual retention grants.



2018 Stock Option Agreement

Exhibit 10.2(h)

(b)    Death and Disability. If the Participant’s Termination is due to the Participant’s death or Disability (for purposes of this Agreement, as defined in the applicable Anthem Long-Term Disability Plan), the Option shall immediately become fully exercisable and shall terminate on the five-year anniversary of the date of such Termination but not later than the Expiration Date noted on the attached Schedule A.
(c)    Termination without Cause. Unless Sections 3(a) or 3(e) are applicable, if the Participant’s Termination is by the Company or an Affiliate without Cause (for purposes of this Agreement, defined as a violation of “conduct” as such term is defined in the Anthem HR Corrective Action Policy and if the Participant participates in the Anthem, Inc. Executive Agreement Plan (the "Agreement Plan"), the Key Associate Agreement or the Key Sales Associate Agreement also as defined in that plan or agreement) or voluntarily by the Participant, the following shall apply:
(i)Unless clause (ii) applies, the Option, to the extent fully exercisable as of the date of such Termination, shall thereafter only be exercisable for a period of ninety (90) days from the date of such Termination, but not later than the Expiration Date noted on the attached Schedule A.
(ii)If the Participant is receiving severance under the Agreement Plan, the Anthem Supplemental Unemployment Benefit Plan, the Anthem Excess Termination Benefit Plan, the Key Associate Agreement or the Key Sales Associate Agreement and any portion of the Option remains unexercisable as of the Participant’s Termination, the Option shall continue to become exercisable through the earlier of (A) the last day of the period for which the Participant is receiving severance or (B) the last day of the schedule set forth in the Grant Notice. The Option shall be exercisable for a period of ninety (90) days from the date the severance period ends, but not later than the Expiration Date noted on the attached Schedule A.

(d)    Cause. If the Participant’s Termination is for Cause, even if on the date of such Termination the Participant has met the definition of Retirement or Disability, then the portion of the Option that has not been exercised shall immediately terminate.
(e)    Termination after Change of Control. If after a Change of Control the Participant’s Termination is (i) by the Company or an Affiliate without Cause or (ii) if the Participant participates in the Executive Agreement Plan, by the Participant for Good Reason (as defined in the Executive Agreement Plan), the Option shall immediately become fully exercisable and shall terminate on the five-year anniversary of the date of such Termination but not later than the Expiration Date noted on the attached Schedule A.
4.    Transferability of the Option. The Option shall not be transferable or assignable by the Participant except as provided in this Section 4 and the Option shall be exercisable, during the Participant’s lifetime, only by him/her or, during periods of legal disability, by his guardian or other legal representative. No Option shall be subject to execution, attachment, or similar process. The Participant shall have the right to appoint any individual or legal entity in writing, on a Designation of Beneficiary form as his/her beneficiary to receive any Option (to the extent not previously terminated or forfeited) under this Agreement upon the Participant’s death. Such designation under this Agreement may be revoked by the Participant at any time and a new beneficiary may be appointed by the Participant by execution and submission to the Company, or its designee, of a revised Designation of Beneficiary form to this Agreement. In order to be effective, a designation of beneficiary must be completed by the Participant on the Designation of Beneficiary form and received by the Company, or its designee, prior to the date of the Participant’s death. If the Participant dies without such designation, the Option may be exercised only by the executor or administrator of the Participant’s estate or by a person who shall have acquired the right to such exercise by will or by the laws of descent and distribution.

5.    Taxes and Withholdings. At the time of receipt of Shares upon the exercise of all or any part of the Option, the Participant shall pay to the Company in cash (or make other arrangements, in accordance with Article XVIII of the Plan, for the satisfaction of) any taxes of any kind required by law to be withheld with respect to such Shares; provided, however, that pursuant to any procedures, and subject to any limitations as the Committee may prescribe and subject to applicable law, the Participant may elect to satisfy, in whole or in part, such withholding



2018 Stock Option Agreement

Exhibit 10.2(h)

obligations by (a) withholding Shares otherwise deliverable to the Participant pursuant to the Option (provided, however, that the amount of any Shares so withheld shall not exceed the amount necessary to satisfy required Federal, state, local and non-United States withholding obligations using the minimum statutory withholding rates for Federal, state, local and/or non-U.S. tax purposes, including payroll taxes, that are applicable to supplemental taxable income) and/or (b) tendering to the Company Shares owned by the Participant (or the Participant and the Participant’s spouse jointly) based, in each case, on the Fair Market Value of the Shares on the payment date as determined by the Committee. Any such election made by the Participant must be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.
6.    No Rights as a Shareholder. Neither the Participant nor any other person shall become the beneficial owner of the Shares subject to the Option, nor have any rights to dividends or other rights as a shareholder with respect to any such Shares, until the Participant has actually received such Shares following the exercise of the Option in accordance with the terms of the Plan and this Agreement.
7.    Restrictive Covenants. As a condition to receipt of the Option Grant made under this Agreement, the Participant agrees as follows:
(a)Confidentiality.

(i)The Participant recognizes that the Company derives substantial economic value from information created and used in its business which is not generally known by the public, including, but not limited to, plans, designs, concepts, computer programs, formulae, and equations; product fulfillment and supplier information; customer and supplier lists, and confidential business practices of the Company, its affiliates and any of its customers, vendors, business partners or suppliers; profit margins and the prices and discounts the Company obtains or has obtained or at which it sells or has sold or plans to sell its products or services (except for public pricing lists); manufacturing, assembling, labor and sales plans and costs; business and marketing plans, ideas, or strategies; confidential financial performance and projections; employee compensation; employee staffing and recruiting plans and employee personal information; and other confidential concepts and ideas related to the Company’s business (collectively, “Confidential Information”). The Participant expressly acknowledges and agrees that by virtue of his/her employment with the Company, the Participant will have access and will use in the course of the Participant’s duties certain Confidential Information and that Confidential Information constitutes trade secrets and confidential and proprietary business information of the Company, all of which is the exclusive property of the Company. For purposes of this Agreement, Confidential Information includes the foregoing and other information protected under the Indiana Uniform Trade Secrets Act (the “Act”), or to any comparable protection afforded by applicable law, but does not include information that the Participant establishes by clear and convincing evidence is or may become known to the Participant or to the public from sources outside the Company and through means other than a breach of this Agreement. Notwithstanding the foregoing, in accordance with the Defend Trade Secrets Act of 2016, the Participant will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If the Participant files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Participant may disclose the Company’s trade secrets to his/her attorney and use the trade secret information in the court proceeding if the Participant (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.

(ii)The Participant agrees that the Participant will not for himself or herself or for any other person or entity, directly or indirectly, without the prior written consent of the Company, while employed by the Company and thereafter: (A) use Confidential Information for the benefit of any person or entity other than the Company or its affiliates; (B) remove, copy, duplicate



2018 Stock Option Agreement

Exhibit 10.2(h)

or otherwise reproduce any document or tangible item embodying or pertaining to any of the Confidential Information, except as required to perform the Participant’s duties for the Company or its affiliates; or (C) while employed and thereafter, publish, release, disclose or deliver or otherwise make available to any third party any Confidential Information by any communication, including oral, documentary, electronic or magnetic information transmittal device or media. Upon termination of employment, the Participant shall return all Confidential Information and all other property of the Company. This obligation of non-disclosure and non-use of information shall continue to exist for so long as such information remains Confidential Information. Provided, however, nothing in this Agreement prohibits or limits the Participant from (i) reporting possible violations of federal securities law or regulation to any governmental agency or entity or (ii) receiving a monetary award from the governmental agency or entity for the information reported.

(b)Non-Competition. During any period in which the Participant is employed by the Company, and during a period of time after the Participant’s termination of employment (the “Restriction Period”) which is (i) twenty-four (24) months for Executive Vice Presidents, (ii) fifteen (15) months for Senior Vice Presidents who became a participant in the Agreement Plan before August 6, 2013, and (iii) the greater of the period of severance or twelve (12) months for all other Participants, the Participant will not, without prior written consent of the Company, directly or indirectly seek or obtain a Competitive Position in a Restricted Territory and perform a Restricted Activity with a Competitor, as those terms are defined herein.

(i)Competitive Position means any employment or performance of services with a Competitor (A) similar to the services in which Participant performed for the Company in the last twenty-four (24) months of Participant’s employment with Company, or (B) in which the Participant will use any Confidential Information of the Company.

(ii)Restricted Territory means any geographic area in which the Company does business and in which the Participant had responsibility for, or Confidential Information about, such business, within the thirty-six (36) months prior to the Participant’s termination of employment from the Company.

(iii)Restricted Activity means any activity for which the Participant had responsibility for the Company within the thirty-six (36) months prior to the termination of the Participant’s employment from the Company or about which the Participant had Confidential Information.

(iv)Competitor means any entity or individual (other than the Company or its affiliates) engaged in management of network-based managed care plans and programs, or the performance of managed care services, health insurance, long term care insurance, dental, life or disability insurance, behavioral health, vision, flexible spending accounts and COBRA administration or other products or services substantially the same or similar to those offered by the Company while the Participant was employed, or other products or services offered by the Company within twelve (12) months after the termination of Participant’s employment if the Participant had responsibility for, or Confidential Information about, such other products or services while the Participant was employed by the Company.

(c)Non-Solicitation of Customers. During any period in which the Participant is employed by the Company, and during the Restriction Period after the Participant’s termination of employment, the Participant will not, either individually or as an employee, partner, consultant, independent contractor, owner, agent, or in any other capacity, directly or indirectly, for a Competitor of the Company as defined in subsection (b) above: (i) solicit business from any client or account of the Company or any of its affiliates with which the Participant had contact, participated in the contact, or responsibility for, or about which the Participant had knowledge of Confidential Information by reason of the Participant’s employment with the Company, (ii) solicit business from any client or account which was pursued by the Company or any of its affiliates and with which the Participant had contact, or responsibility for, or about which the Participant had knowledge of Confidential Information by reason of the Participant’s employment



2018 Stock Option Agreement

Exhibit 10.2(h)

with the Company, within the twelve (12) month period prior to termination of employment. For purposes of this provision, an individual policyholder in a plan maintained by the Company or by a client or account of the Company under which individual policies are issued, or a certificate holder in such plan under which group policies are issued, shall not be considered a client or account subject to this restriction solely by reason of being such a policyholder or certificate holder.
(d)Non-Solicitation of Employees. During any period in which the Participant is employed by the Company, and during the Restriction Period after the Participant’s termination of employment, the Participant will not, either individually or as an employee, partner, independent contractor, owner, agent, or in any other capacity, directly or indirectly solicit, hire, attempt to solicit or hire, or participate in any attempt to solicit or hire, for any non-Company affiliated entity, any person who on or during the six (6) months immediately preceding the date of such solicitation or hire is or was an officer or employee of the Company, or whom the Participant was involved in recruiting while the Participant was employed by the Company.

(e)Non-Disparagement. The Participant agrees that he/she will not, nor will he/she cause or assist any other person to, make any statement to a third party or take any action which is intended to or would reasonably have the effect of disparaging or harming the Company or the business reputation of the Company’s directors, employees, officers and managers. Further, the Participant will not at any time make any verbal or written statement to any media outlet regarding the Company.

8.    Return of Consideration.

(a)    If at any time a Participant breaches any provision of Section 7 or Section 11 then: (i) all unexercised Company stock options under any Designated Plan (defined below) whether or not otherwise vested shall cease to be exercisable and shall immediately terminate; (ii) the Participant shall forfeit any outstanding restricted stock or other outstanding equity award made under any Designated Plan and not otherwise vested on the date of breach; and (iii) the Participant shall pay to the Company (A) for each share of common stock of the Company (“Common Share”) acquired on exercise of an option under a Designated Plan within the 24 months prior to such breach, the excess of the fair market value of a Common Share on the date of exercise over the exercise price, and (B) for each share of restricted stock that became vested under any Designated Plan within the 24 months prior to such breach, the fair market value (on the date of vesting) of a Common Share. Any amount to be repaid pursuant to this Section 8 shall be held by the Participant in constructive trust for the benefit of the Company and shall, upon written notice from the Company, within 10 days of such notice, be paid by the Participant to the Company with interest from the date such Common Share was acquired or the share of restricted stock became vested, as the case may be, to the date of payment, at 120% of the applicable six month short-term AFR. Any amount described in clauses (i) and (ii) that the Participant forfeits as a result of a breach of the provisions of Sections 7 or 11 shall not reduce any money damages that would be payable to the Company as compensation for such breach.

(b)    The amount to be repaid pursuant to this Section 8 shall be determined on a gross basis, without reduction for any taxes incurred, as of the date of the realization event, and without regard to any subsequent change in the fair market value of a Common Share. The Company shall have the right to offset such amount against any amounts otherwise owed to the Participant by the Company (whether as wages, vacation pay, or pursuant to any benefit plan or other compensatory arrangement other than any amount pursuant to any nonqualified deferred compensation plan under Section 409A of the Code).

(c)    For purposes of this Section 8, a “Designated Plan” is each stock option, restricted stock, or other equity compensation or long-term incentive compensation plan.

9.
Equitable Relief and Other Remedies. As a condition to this Agreement:
(a)    The Participant acknowledges that each of the provisions of Section 7 and 8 of the Plan are reasonable and necessary to preserve the legitimate business interests of the Company, its present and potential business activities and the economic benefits derived therefrom; that they will not prevent him or her from earning a livelihood in the Participant’s chosen business and are not an undue restraint on the trade of the Participant, or any of the public interests which may be involved.



2018 Stock Option Agreement

Exhibit 10.2(h)


(b)    The Participant agrees that beyond the amounts otherwise to be provided under the Plan and this Agreement, the Company will be damaged by a violation of the terms of this Agreement and the amount of such damage may be difficult to measure. The Participant agrees that if the Participant commits or threatens to commit a breach of any of the covenants and agreements contained in Sections 7 or 11 to the extent permitted by applicable law, then the Company shall have the right to seek and obtain all appropriate injunctive and other equitable remedies, without posting bond therefor, except as required by law, in addition to any other rights and remedies that may be available at law or under this Agreement, it being acknowledged and agreed that any such breach would cause irreparable injury to the Company and that money damages would not provide an adequate remedy. Further, if the Participant violates Section 7 hereof the Participant agrees that the period of violation shall be added to the period in which the Participant’s activities are restricted.

(c)    Notwithstanding the foregoing, the Company will not seek injunctive relief to prevent a Participant residing in California from engaging in post termination competition in California under Section 7(b) or (c) of this Agreement, provided that the Company may seek and obtain relief to enforce Section 8 of this Agreement with respect to such Participants.

(d)    The parties agree that the covenants contained herein are severable. If an arbitrator or court shall hold that the duration, scope, area or activity restrictions stated herein are unreasonable under circumstances then existing, the parties agree that the maximum duration, scope, area or activity restrictions reasonable and enforceable under such circumstances shall be substituted for the stated duration, scope, area or activity restrictions to the maximum extent permitted by law. The parties further agree that the Company’s rights under Section 8 should be enforced to the fullest extent permitted by law irrespective of whether the Company seeks equitable relief in addition to relief provided therein or if the arbitrator or court deems equitable relief to be inappropriate.

10.    Survival of Provisions. The obligations contained in Sections 7, 8, 9 and Section 11 shall survive the Termination of the Participant’s employment with the Company and shall be fully enforceable thereafter.

11.    Cooperation. Upon the receipt of reasonable notice from the Company (including from outside counsel to the Company), the Participant agrees that while employed by the Company and for two years (or, if longer, for so long as any claim referred to in this Section remains pending) after the termination of Participant’s employment for any reason, the Participant will respond and provide information with regard to matters in which the Participant has knowledge as a result of the Participant’s employment with the Company, and will provide reasonable assistance to the Company, its affiliates and their respective representatives in defense of any claims that may be made against the Company or its affiliates, and will assist the Company and its affiliates in the prosecution of any claims that may be made by the Company or its affiliates, to the extent that such claims may relate to the period of the Participant’s employment with the Company (or any predecessor); provided, that with respect to periods after the termination of the Participant’s employment, the Company shall reimburse the Participant for any out-of-pocket expenses incurred in providing such assistance and if the Participant is required to provide more than ten (10) hours of assistance per week after his termination of employment then the Company shall pay the Participant a reasonable amount of money for his services at a rate agreed to between the Company and the Participant; and provided further that after the Participant’s termination of employment with the Company such assistance shall not unreasonably interfere with the Participant’s business or personal obligations. The Participant agrees to promptly inform the Company if the Participant becomes aware of any lawsuits involving such claims that may be filed or threatened against the Company or its affiliates. The Participant also agrees to promptly inform the Company (to the extent the Participant is legally permitted to do so) if the Participant is asked to assist in any investigation of the Company or its affiliates (or their actions), regardless of whether a lawsuit or other proceeding has then been filed against the Company or its affiliates with respect to such investigation, and shall not do so unless legally required. Provided, however, the Participant is not required to inform the Company of any investigation by a governmental agency or entity resulting from the reporting of possible violations of federal securities law or regulation to any governmental agency or entity, and the Participant may participate in such investigation, without informing the Company.

12.    No Right to Continued Employment. Neither the Option nor any terms contained in this Agreement shall confer upon the Participant any express or implied right to be retained in the employment or service



2018 Stock Option Agreement

Exhibit 10.2(h)

of the Company or any Affiliate for any period, nor restrict in any way the right of the Company, which right is hereby expressly reserved, to terminate the Participant’s employment or service at any time with or without Cause. The Participant acknowledges and agrees that any right to exercise the Option is earned only by continuing as an employee of the Company or an Affiliate at the will of the Company or such Affiliate, or satisfaction of any other applicable terms and conditions contained in the Plan and this Agreement, and not through the act of being hired, being granted the Option or acquiring Shares hereunder.

13.    The Plan. This Agreement is subject to all the terms, provisions and conditions of the Plan, which are incorporated herein by reference, and to such regulations as may from time to time be adopted by the Committee. Unless defined herein, capitalized terms are as defined in the Plan. In the event of any conflict between the provisions of the Plan and this Agreement, the provisions of the Plan shall control, and this Agreement shall be deemed to be modified accordingly. The Plan and the prospectus describing the Plan can be found on the Company’s HR intranet. A paper copy of the Plan and the prospectus shall be provided to the Participant upon the Participant’s written request to the Company at Anthem, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention: Corporate Secretary, Shareholder Services Department.

14.    Compliance with Laws and Regulations.

(a)    The Option and the obligation of the Company to sell and deliver Shares hereunder shall be subject in all respects to (i) all applicable Federal and state laws, rules and regulations and (ii) any registration, qualification, approvals or other requirements imposed by any government or regulatory agency or body which the Committee shall, in its discretion, determine to be necessary or applicable. Moreover, the Option may not be exercised if its exercise, or the receipt of Shares pursuant thereto, would be contrary to applicable law. If at any time the Company determines, in its discretion, that the listing, registration or qualification of Shares upon any national securities exchange or under any state or Federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable, the Company shall not be required to deliver any certificates for Shares to the Participant or any other person pursuant to this Agreement unless and until such listing, registration, qualification, consent or approval has been effected or obtained, or otherwise provided for, free of any conditions not acceptable to the Company.

(b)    The Shares received upon the exercise of the Option shall have been registered under the Securities Act of 1933 (“Securities Act”). If the Participant is an “affiliate” of the Company, as that term is defined in Rule 144 under the Securities Act (“Rule 144”), the Participant may not sell the Shares received except in compliance with Rule 144. Certificates representing Shares issued to an “affiliate” of the Company may bear a legend setting forth such restrictions on the disposition or transfer of the Shares as the Company deems appropriate to comply with Federal and state securities laws.

(c)    If at the time of exercise of all or part of the Option, the Shares are not registered under the Securities Act, and/or there is no current prospectus in effect under the Securities Act with respect to the Shares, the Participant shall execute, prior to the delivery of any Shares to the Participant by the Company pursuant to this Agreement, an agreement (in such form as the Company may specify) in which the Participant represents and warrants that the Participant is purchasing or acquiring the shares acquired under this Agreement for the Participant's own account, for investment only and not with a view to the resale or distribution thereof, and represents and agrees that any subsequent offer for sale or distribution of any kind of such Shares shall be made only pursuant to either (i) a registration statement on an appropriate form under the Securities Act, which registration statement has become effective and is current with regard to the Shares being offered or sold, or (ii) a specific exemption from the registration requirements of the Securities Act, but in claiming such exemption the Participant shall, prior to any offer for sale of such Shares, obtain a prior favorable written opinion, in form and substance satisfactory to the Company, from counsel for or approved by the Company, as to the applicability of such exemption thereto.

15.    Notices. All notices by the Participant or the Participant’s assignees shall be addressed to Anthem, Inc., 120 Monument Circle, Indianapolis, Indiana 46204, Attention: Stock Administration, or such other address as the Company may from time to time specify. All notices to the Participant shall be addressed to the Participant at the Participant’s address in the Company's records.




2018 Stock Option Agreement

Exhibit 10.2(h)

16.    Other Plans. The Participant acknowledges that any income derived from the exercise of the Option shall not affect the Participant’s participation in, or benefits under, any other benefit plan or other contract or arrangement maintained by the Company or any Affiliate.

17.    Recoupment Policy for Incentive Compensation. The Company's Recoupment Policy for Incentive Compensation, as may be amended from time to time, shall apply to the Option, any Shares acquired upon exercise of the Option and any profits realized from the sale of such Shares to the extent that the Participant is covered by such policy. If the Participant is covered by such policy, the policy may apply to recoup the Option, any Shares acquired upon exercise of the Option or profits realized from the sale of Shares previously covered by the Option either before, on or after the date on which the Participant becomes subject to such policy.



ANTHEM, INC.

By:        ______________________________
Printed:    Lewis Hay III
    Its:    Chair, Compensation Committee of the
Board of Directors




2018 Stock Option Agreement

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:7/25/188-K
For Period end:6/30/18
8/6/134
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/21/24  Elevance Health, Inc.             10-K       12/31/23  153:25M
 2/15/23  Elevance Health, Inc.             10-K       12/31/22  152:27M
 2/16/22  Elevance Health, Inc.             10-K       12/31/21  153:26M
 2/18/21  Elevance Health, Inc.             10-K       12/31/20  160:28M
Top
Filing Submission 0001156039-18-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 4:17:56.1pm ET